| __timestamp | Pfizer Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8393000000 | 19586000 |
| Thursday, January 1, 2015 | 7690000000 | 29135000 |
| Friday, January 1, 2016 | 7872000000 | 42791000 |
| Sunday, January 1, 2017 | 7657000000 | 49577000 |
| Monday, January 1, 2018 | 8006000000 | 89209000 |
| Tuesday, January 1, 2019 | 8650000000 | 69099000 |
| Wednesday, January 1, 2020 | 9405000000 | 75961000 |
| Friday, January 1, 2021 | 13829000000 | 90467000 |
| Saturday, January 1, 2022 | 11428000000 | 74552000 |
| Sunday, January 1, 2023 | 10679000000 | 91593000 |
| Monday, January 1, 2024 | 10930000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, research and development (R&D) investment is crucial for innovation and growth. Over the past decade, Pfizer Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting R&D strategies. Pfizer, a global giant, consistently invested heavily, with a peak in 2021, where R&D expenses surged by approximately 80% compared to 2014. This reflects Pfizer's commitment to maintaining its competitive edge through innovation.
Conversely, Supernus Pharmaceuticals, a smaller player, showed a steady increase in R&D spending, peaking in 2023 with a 368% rise from 2014. This growth underscores Supernus's strategic focus on expanding its niche in the market. The data highlights the diverse approaches within the industry, where both giants and niche players strive for breakthroughs, albeit with different scales and strategies.
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.